BAFF/BLyS Receptor 3 Binds the B Cell Survival Factor BAFF Ligand Through a Discrete Surface Loop and Promotes Processing of NF-kappaB2
Overview
Authors
Affiliations
The TNF-like ligand BAFF/BLyS is a potent survival factor for B cells. It binds three receptors: TACI, BCMA, and BR3. We show that BR3 signaling promotes processing of the transcription factor NF-kappaB2/p100 to p52. NF-kappaB2/p100 cleavage was abrogated in B cells from A/WySnJ mice possessing a mutant BR3 gene, but not in TACI or BCMA null B cells. Furthermore, wild-type mice injected with BAFF-neutralizing BR3-Fc protein showed reduced basal NF-kappaB2 activation. BR3-Fc treatment of NZB/WF1 mice, which develop a fatal lupus-like syndrome, inhibited NF-kappaB2 processing and attenuated the disease process. Since inhibiting the BR3-BAFF interaction has therapeutic ramifications, the ligand binding interface of BR3 was investigated and found to reside within a 26 residue core domain. When stabilized within a structured beta-hairpin peptide, six of these residues were sufficient to confer binding to BAFF.
Genes Co-Expressed with Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis.
Lipowicz J, Malinska A, Nowicki M, Rawluszko-Wieczorek A Int J Mol Sci. 2024; 25(16).
PMID: 39201394 PMC: 11354723. DOI: 10.3390/ijms25168707.
Revisiting Neuroblastoma: Nrf2, NF-κB and Phox2B as a Promising Network in Neuroblastoma.
Peggion S, Najem S, Kolman J, Reinshagen K, Pagerols Raluy L Curr Issues Mol Biol. 2024; 46(4):3193-3208.
PMID: 38666930 PMC: 11048850. DOI: 10.3390/cimb46040200.
NF-κB in biology and targeted therapy: new insights and translational implications.
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M Signal Transduct Target Ther. 2024; 9(1):53.
PMID: 38433280 PMC: 10910037. DOI: 10.1038/s41392-024-01757-9.
Roy K, Chakraborty M, Kumar A, Manna A, Roy N Front Immunol. 2024; 14:1185597.
PMID: 38169968 PMC: 10758606. DOI: 10.3389/fimmu.2023.1185597.
NF-kB's contribution to B cell fate decisions.
Guldenpfennig C, Teixeiro E, Daniels M Front Immunol. 2023; 14:1214095.
PMID: 37533858 PMC: 10391175. DOI: 10.3389/fimmu.2023.1214095.